(Q36711181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

review article

1 reference

title

Patient adherence to osteoporosis medications: problems, consequences and management strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Alexandra Papaioannou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Courtney C Kennedy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Elaine Lau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Jonathan D Adachi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

37-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17233546%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002512-200724010-00003

24 December 2019

exact match

0 references

cites work

Gastrointestinal side effect profile due to the use of alendronate in the treatment of osteoporosis.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200724010-00003

Treatment preference and tolerability with alendronate once weekly over a 3-month period: an Israeli multi-center study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200724010-00003

Effects of an osteoporosis prevention program incorporating tailored educational materials

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002512-200724010-00003

Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women

21 January 2018

1 reference

12 December 2020

Compliance with pharmacologic therapy for osteoporosis

1 reference

12 December 2020

Compliance with osteoporosis medications

1 reference

12 December 2020

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study

1 reference

12 December 2020

Early discontinuation of treatment for osteoporosis

1 reference

12 December 2020

Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study

1 reference

12 December 2020

Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications

1 reference

12 December 2020

Adherence, patient preference and dosing frequency: understanding the relationship

1 reference

12 December 2020

A family history of fracture and fracture risk: a meta-analysis.

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology

1 reference

12 December 2020

A model of lifetime osteoporosis impact.

1 reference

12 December 2020

Determinants of long-term hormone replacement therapy and reasons for early discontinuation

1 reference

12 December 2020

Interventions for enhancing medication adherence

1 reference

12 December 2020

Can simple clinical measurements detect patient noncompliance?

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women

1 reference

12 December 2020

Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women

1 reference

12 December 2020

Compliance with drug therapies for the treatment and prevention of osteoporosis

1 reference

12 December 2020

Osteoporosis screening and education in community pharmacies using a team approach

1 reference

12 December 2020

Patient compliance and the conduct and interpretation of therapeutic trials.

1 reference

12 December 2020

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

1 reference

12 December 2020

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

1 reference

12 December 2020

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

1 reference

12 December 2020

Adherence to Medication

1 reference

12 December 2020

Meta-analysis of trials of interventions to improve medication adherence

1 reference

12 December 2020

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Observational study of compliance and continuance rates of raloxifene in the prevention and treatment of osteoporosis

1 reference

12 December 2020

Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.

1 reference

12 December 2020

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

1 reference

12 December 2020

A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Calcium plus vitamin D supplementation and the risk of fractures

1 reference

12 December 2020

Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care

1 reference

12 December 2020

A meta-analysis of previous fracture and subsequent fracture risk

1 reference

12 December 2020

Determinants of adherence to osteoporosis treatment in clinical practice

1 reference

12 December 2020

Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis

1 reference

12 December 2020

Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women.

1 reference

12 December 2020

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

1 reference

12 December 2020

Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats.

1 reference

12 December 2020

A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk

1 reference

12 December 2020

Pharmacy-based bone mass measurement to assess osteoporosis risk

1 reference

12 December 2020

The osteoporosis care gap in Canada

1 reference

12 December 2020

Osteoporosis. Frequency, consequences, and risk factors

1 reference

12 December 2020

Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis

1 reference

12 December 2020

Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey.

1 reference

12 December 2020

Persistence with hypertension treatment among community-dwelling BC seniors

1 reference

12 December 2020

Effect of age on reasons for initiation and discontinuation of hormone replacement therapy

1 reference

12 December 2020

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

1 reference

12 December 2020

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

1 reference

12 December 2020

Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate

1 reference

12 December 2020

Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds

1 reference

12 December 2020

Epidemiology of osteoporotic fractures

1 reference

12 December 2020

Predictive Value of BMD for Hip and Other Fractures

1 reference

12 December 2020

Patients with osteoporosis prefer once weekly to once daily dosing with alendronate

1 reference

12 December 2020

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Long-term outcome of weekly bisphosphonates

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Compliance of osteoporotic patients with different treatment regimens

1 reference

12 December 2020

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Tolerability and compliance with risedronate in clinical practice

1 reference

12 December 2020

Estrogen replacement therapy: determinants of persistence with treatment

1 reference

12 December 2020

Concurrent and predictive validity of a self-reported measure of medication adherence

1 reference

12 December 2020

Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database

1 reference

12 December 2020

Factors that influence adherence to calcium recommendations

1 reference

12 December 2020

Management of corticosteroid-induced osteoporosis

1 reference

12 December 2020

Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients' compliance by using computerised pharmacy data

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women

1 reference

12 December 2020

Hormone replacement therapy for postmenopausal osteoporosis

1 reference

12 December 2020

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms

1 reference

12 December 2020

Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

1 reference

12 December 2020

Does follow-up of osteoporotic women treated with antiresorptive therapies improve effectiveness?

1 reference

12 December 2020